Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (5) , 875-880
- https://doi.org/10.1016/0006-2952(88)90175-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Enzyme targets of antiglutamine agents in cancer chemotherapyAdvances in Enzyme Regulation, 1985
- Acivicin in 1985Advances in Enzyme Regulation, 1985
- Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinomaBiochemical Pharmacology, 1985
- In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatomaBiochemical Pharmacology, 1985
- Multi-enzyme-targeted chemotherapy by acivicin and actinomycinAdvances in Enzyme Regulation, 1982
- Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)Biochemical Pharmacology, 1982
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- In vivo inactivation by acivicin of carbamoylphosphate synthetase II in rat hepatomaBiochemical Pharmacology, 1982
- Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatomaLife Sciences, 1982
- 2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesJournal of Medicinal Chemistry, 1982